MannKind Corporation (NASDAQ:MNKD) shareholders have a smile on their faces Wednesday evening, after the drug maker announced that it has entered into a supply and …
Investors are most pleased with MannKind Corporation (NASDAQ:MNKD) new leadership, sending shares nearly 10%, as of this writing. The inhaled insulin maker announced this morning …
In a research report released Thursday, J.P.
MannKind Corporation (NASD:MNKD) and One Drop announced that they have signed a memorandum of understanding to enter into a collaborative agreement that would …
David E. Shaw, quant genius and hedge fund manager billionaire extraordinaire founded DE Shaw as a sharp mathematical models-meets-algorithms dual-powered firm.
MannKind Corporation (NASDAQ:MNKD) reported financial results for the fourth quarter and full year ended December 31, 2016. Key results include: Total revenue for …
MannKind Corporation (NASDAQ:MNKD) and Bella & Elle Media LLC announce MannKind’s sponsorship of “Reversed,” a production series aimed at educating the show’s participants …
MannKind Corporation (NASDAQ:MNKD) announced the launch of a new Titration Pack containing 60 — 4 unit cartridges, 60 — 8 unit cartridges and …
MannKind Corporation (NASDAQ:MNKD) announced that Stuart A. Tross, Ph.
MannKind Corporation (NASDAQ:MNKD) announced the confirmation that following the completion of initial formulation studies it received a $1 million milestone payment from Receptor Life Sciences, …
